TrialAnnals of the rheumatic diseases2016

MRI assessment of suppression of structural damage in patients with rheumatoid arthritis receiving rituximab: results from the randomised, placebo-controlled, double-blind RA-SCORE study.

Charles Peterfy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.